DBM LLC

DBM LLC, operating as Limb Lab, manufactures and supplies prosthetic limbs, components, and related medical devices to the Department of Veterans Affairs as a prime contractor on 100% of recent awards, competing on a full-and-open (non-set-aside) basis. The company is a for-profit limited liability partnership based in Rochester, Minnesota, classified under NAICS 339113 (Surgical Appliance and Supplies Manufacturing) and PSC 6520 (Medical and Surgical Instruments, Equipment, and Supplies). Limb Lab holds a self-certification as a small disadvantaged business but does not carry SBA 8(a), HUBZone, SDVOSB, or other formal small-business set-aside designations across its federal footprint.

Limb Lab's customer concentration is nearly total within the VA system. Veterans Integrated Service Network 23 (Minneapolis-serving region) anchors 21 of 32 awards with $534 thousand in combined potential value—78% of the vendor's $688 thousand total federal portfolio. The Federal Medical Center Rochester (a Bureau of Prisons facility) supplies 7 awards valued at $73 thousand, while VISN 12, VISN 19, and VISN 7 contribute smaller volumes (2, 1, and 1 awards respectively). The two customer-ranking lists align identically — no tension between volume and dollar concentration. All awards are firm fixed-price purchase orders for specific prosthetic devices: artificial limbs, prosthetic knees and shins, socket replacements, and electronic prosthetic components. Recent representative work includes a $78,659 artificial left limb delivery to VISN 23 awarded October 21, 2025 (completion October 20, 2026), a $65,539 artificial arm to VISN 23 awarded September 4, 2025 (completion September 3, 2026), a $20,973 prosthetic services contract with Federal Medical Center Rochester awarded January 1, 2025 (completion February 11, 2025), and a $44,204 OSSUR PROFLEX supply order to VISN 7 awarded February 20, 2026 (completion April 30, 2026).

Activity has fluctuated modestly over the past five years—two awards in 2022, four in 2023, three in 2024, five in 2025, and one in 2026 year-to-date—with $675 thousand in combined dollars obligated against $688 thousand in potential value (98% obligation rate). Two awards with combined potential value of $144 thousand face ultimate completion within the next twenty-four months and therefore expose Limb Lab to recompete activity. The vendor operates exclusively as a prime on federal contracts; it has no subcontract footprint in the source data. Limb Lab established its federal contracting presence in 2015 and has delivered over $300 thousand cumulatively to the VA system, with the recent award trajectory and narrow customer concentration suggesting a specialized, stable, regional supplier relationship to midwestern VA medical facilities rather than a growth-oriented federal enterprise.